Form 4: Sera Prognostics Director Sells Shares Under 10b5-1 Plan

A director of Sera Prognostics, Joshua Phillips, sold shares of Class A Common Stock through a pre-arranged 10b5-1 trading plan.

Summary

• Joshua Phillips, a director at Sera Prognostics, sold shares of Class A Common Stock.
• The sales were executed between January 10, 2025 and January 14, 2025.
• The transactions were made under a pre-arranged Rule 10b5-1 trading plan adopted on June 10, 2024.
• The shares were sold at varying prices, with weighted average prices reported for each day.
• The shares were sold both directly and indirectly through various investment funds associated with Catalyst Health Ventures.
• The director disclaims beneficial ownership of the indirectly held shares except to the extent of his pecuniary benefit.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock sales by a director under a pre-arranged plan. It doesn't indicate any positive or negative sentiment about the company's performance, but the sales could be interpreted as a slight negative.

Risks

• The sales by a director could be perceived negatively by the market, potentially impacting the stock price.
• The use of a 10b5-1 plan suggests the director may continue to sell shares in the future.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders who trade company stock. The use of a 10b5-1 plan is a common practice to avoid accusations of insider trading.

Comparison to Industry Standards

• Form 4 filings are a standard part of corporate governance and are common across all publicly traded companies.
• The use of 10b5-1 trading plans is a common practice among corporate insiders to manage their stock sales in a compliant manner.
• The reported transactions are similar to those of other directors and officers who sell shares in their companies.

Stakeholder Impact

• Shareholders may react to the director's stock sales, potentially impacting the stock price.
• The sales do not directly impact employees, customers, suppliers, or creditors.

Key Dates

Keywords

Sera Prognostics, Joshua Phillips, insider trading, Form 4, stock sale, 10b5-1 plan, Catalyst Health Ventures, Class A Common Stock